Among recent updates available from the European Commission are the following: Manual on borderline and classification for medical devices under Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices, Version 5 dated April 2026 MDCG 2021-24 Rev.1, Guidance on classification of medical devices Manufacturer Incident Report MIR PDF…
The central medical device database, EUDAMED – a key EU medical device regulatory infrastructure – will become mandatory from 28 May 2026. Preparing for EUDAMED readiness requires a cross-functional transformation, involving teams across regulatory affairs, quality, R&D, labelling, product data management and commercial functions. To support senior business leaders in understanding the strategic implications, MedTech…
The International Medical Device Regulators Forum (IMDRF) has released a draft technical document, titled ‘Technical Framework for Artificial Intelligence Life Cycle Management’, to propose a harmonized set of best practices in mitigating risks associated with the use of artificial intelligence (AI)-enabled medical devices throughout their product life cycle. The guidance states that “the GMLP principles…
ISO 14155 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices. The new edition ISO 14155:2026 has been made available by ISO in English, French, and with redlines showing the changes from the…
The UK MHRA has today published its promised public consultation on indefinite recognition of CE marked medical devices for the Great Britain (GB) (England, Scotland, and Wales) market (Northern Ireland already accepts CE marked devices). The consultation invites views on the following proposals: Extending the current transitional arrangements for devices that comply with the Medical…
The US Food and Drug Administration (FDA) has reissued a final guidance on quality system management considerations for medical device cybersecurity following the agency’s transition from the Quality System Regulation (QSR) to the Quality System Management Regulation (QMSR, 21 CFR 820). The new guidance replaces references to the QSR with references to the QMSR and,…
For the second time in a month, the US Food and Drug Administration (FDA) has updated its guidance on Clinical Decsion Support (CDS) Software. The Agency published its first final guidance on the subject in 2022, but then issued an updated version on 6 January 2026, which was superseded by a further version on 29…
In Commission Implementing Decision (EU) 2026/197 of 28 January 2026 , the Commission has announced that a further 6 standards have been harmonised under the Medical Device Regulation (MDR, 2017/745), as follows:
In Commission Implementing Decision (EU) 2026/193, the Commission has announced that a further 12 standards have been harmonised under the Medical Device Regulation (MDR, 2017/745), as follows:
To coincide with mandatory use of the Agency’s Quality Management System Regulation (QMSR, 21 CFR 820) requirements, FDA has also replaced its ‘Quality System Inspection Technique’ (QSIT) guidance for Inspectors with a ‘Compliance Program Manual: Inspection of Medical Device Manufacturers’, with effect from 2 February 2026, explaining that the program has been updated to align…
